• SP2509: Lysine-Specific Demethylase 1 Antagonist

  2026-09-08

  SP2509 provides a focused way to interrogate LSD1-dependent chromatin regulation, apoptosis induction in AML cells, and differentiation-linked transcriptional recovery. Its biochemical selectivity, compatibility with chromatin assays, and reported synergy with HDAC inhibition make it useful for mechanism-first cancer epigenetics workflows.

• AZD8055: Practical mTOR Inhibitor Workflow

  2026-09-08

  AZD8055 is an ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer-cell proliferation, and metabolic responses. It is best suited to mechanistic preclinical workflows, not clinical efficacy conclusions or assays that require an aqueous formulation.

• EZ Cap™ Firefly Luciferase mRNA (m1Ψ) Guide

  2026-09-07

  Use this bioluminescent reporter mRNA to quantify delivery, translation, cell health, and expression kinetics in one adaptable workflow. The article also translates recent findings on modified nucleosides into practical decisions for assay controls and future mRNA design.

• Artesunate: From Viability to Cell Death

  2026-09-07

  Artesunate research is often judged by a single viability value, yet that value may combine growth arrest and cell killing. This article presents a response-phenotyping framework that connects Artesunate mechanism, assay design, and more defensible interpretation in cancer models.

• SN-38 Disrupts FUBP1–FUSE DNA Binding

  2026-09-05

  The reference study identifies an additional activity of camptothecin and SN-38: inhibition of the interaction between the oncogenic transcriptional regulator FUBP1 and its single-stranded DNA target FUSE. By combining compound screening, AlphaScreen binding assays, and cellular gene-expression analysis, the authors connect topoisomerase I inhibitor pharmacology with transcriptional regulation in hepatocellular carcinoma.

• Amitriptyline HCl: Practical Lab Workflow

  2026-09-04

  Amitriptyline HCl (SKU B2231) provides a characterized small molecule for controlled neurotransmitter receptor modulation studies, with defined reference activities, solubility, purity, and storage conditions. It is suitable for exploratory neuropharmacology research when assay-specific controls are used, but it should not be treated as evidence of therapeutic efficacy, receptor selectivity, or performance in a particular disease model.

• GST-Driven Insecticide Resistance in M. usitatus

  2026-09-04

  The reference study identifies MuGSTs1 and GST-mediated antioxidant defense as important contributors to lambda-cyhalothrin resistance in Megalurothrips usitatus. Pharmacological GST inhibition with diethyl maleate reduced antioxidant capacity and markedly increased insecticide sensitivity, providing a mechanistic framework for resistance research and pest-management strategy design.

• GSK343: From EZH2 Mechanism to Translation

  2026-09-03

  A thought-leadership guide to using GSK343 as a selective EZH2 inhibitor for mechanistic epigenetic cancer research, with a translational framework connecting PRC2 biology, H3K27me3 control, and emerging APEX2–TERT findings.

• NP-40 Lysis Buffer for Neuroimmune Assays

  2026-09-03

  NP-40 Lysis Buffer can preserve native protein assemblies and phosphorylation states needed to interpret neuroimmune signaling. This guide develops an assay-selection framework linking extraction chemistry to FPR2/ALX, SYK-AKT, microglial, and NK-cell experiments.

• 7-Ethyl-10-hydroxycamptothecin Workflows

  2026-09-02

  Build more informative cancer assays with 7-Ethyl-10-hydroxycamptothecin, combining topoisomerase I inhibition, cell-cycle profiling, apoptosis measurements, and FUBP1–FUSE binding studies. This practical guide emphasizes fresh DMSO handling, time-resolved dosing, metastatic colon cancer models, and troubleshooting for reproducible advanced colon cancer research.

• DAPI Nuclear Stain Solution: Practical Protocol

  2026-09-02

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution, SKU K2402, provides a pre-diluted fluorescent DNA binding dye for nuclear visualization and endpoint assessment of membrane-compromised cells. It is suited to fixed-cell fluorescence microscopy and selected flow cytometry workflows, but its weak cell permeability limits routine staining of intact live cells.

• Obeticholic Acid: Designing Better FXR Assays

  2026-09-01

  Obeticholic Acid is a selective FXR agonist for mechanistic studies of bile acid homeostasis, cholestasis, and liver fibrosis. This article presents an assay-centered framework that connects FXR gene regulation with the Notch and NK-cell findings reported in recent fibrosis research without conflating distinct mechanisms.

• Central Control of Opioid Mechanical Hypersensitivity

  2026-08-31

  Yin et al. identify a brain-to-spinal opioid circuit that links repeated morphine exposure to mechanical hypersensitivity and analgesic tolerance in mice. The study separates mechanical pain adaptations from thermal effects and provides a circuit-level framework for opioid receptor signaling research and chronic pain research.

• Sodium-Driven Mitochondrial Failure in NECSO

  2026-08-31

  Qiao and colleagues show that TRPM4-mediated sodium influx drives NECSO by disrupting mitochondrial ion handling, oxidative phosphorylation, and the TCA cycle rather than acting only through plasma-membrane ion imbalance. The work establishes a mechanistic connection between sodium overload, ATP failure, Na/K-ATPase collapse, cellular swelling, and necrotic lysis, providing a framework for targeted mitochondrial function analysis.

• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-08-30

  Oh et al. developed and validated a scalable human iPSC-derived sensory neuron system that supports HSV-1 latency and experimentally induced reactivation. The model combines neuronal function with virological and chromatin-based latency criteria, providing a more human-relevant platform for studying neuron-intrinsic mechanisms and antiviral strategies.

8580 records 1/572 page Next 12345 下5页 Last page